: ... , , , , . , , , 38. , , .
- . - , - . , , , I 60% 39. , , , 8 90%40, 41. ( . , 150 . , , , , 12 , 2,5 )42.
37 Moscowitz R. The Case Against Immunizations. Journal of the American Institute of Home
opathy March 1983; 76:7. . ().
38 . . . , 2001, . 71,
5. . : . . : . ., 2002, . 273.
39 Classen J. . Diabetes epidemic follows hepatitis B immunization program. New Zealand
MedicalJournal 1996; (109):195.
40 DeStefano F. The timing of hepatitis immunization and risk of insulin dependent diabetes
mellitus. Pharmacoepidemiology and Drug Safety 1997(6):2-60.
41 Classen D. C, Classen J. B. The timing of pediatric immunization and the risk of insulin-de-
pendent diabetes mellitus. Infectious Diseases in Clinical Practice 1997(6):449-54.
42 WebMD Medical News 13 2000 .
. - , (), ( )43, 14 , 100 . , - , , , , , , , , , . , - , , , ( , ) .
|
|
, , , , 44.
43
- , , ,
.
, , -
.
44 : »
, ,
,
. »
. ,
( . . .) { . . ...).
. , -
, ? , ,
? : -
, 7 ,
,
90-95% , ! . : , -; MMR ( , ) , ; . -... , : . , , , , . - 45. ! , , , () ; , , ...
|
|
, ( )
. , , . : . , , , . , , . ( . . .)( . 21 2005). , , , . , , . , , , , .
45 . . . . , 2000, . 36.
: ( 1 10% ) , ; ( 1%) , , , , , , , , , , , , , -, , , . , , -; ( ), , , . , , , , , . , , , -46, . 47.
, () , , ( ) -, , , 48. , , , 1994 . , ( REACTIONS VAERS) . , . , , , ...
|
|
46 - . Khamaisi M. et al. Guillain-Barre syndrome following hepatitis vaccination. Clinical and Experimental Rheumatology 2004; 22:767-770.
47 Deisenhammer F. et al. Acute cerebellar ataxia after immunisation with recombinant hepatitis vaccine. ActaNeurol. Scand. June 1994; 89(6):462-3.
48 Stratton K. Adverse... p. 9. . Hepatitis vaccine, pp. 211-235.
, - 49. , 1998 . . , , . , , 2001 . , ... !50 , , , , ; - . , , , , , , . . , , ( ), , , 51. , 1993 2000 ., , ...52.
49 Antona D., Levy-Bruhl D. Epidemiology of hepatitis in France at the end of the 20th century.
Medecine et Maladies Infectieuses 2003; 33 (Suppl A):34-41.
50 - (. . 34) 12
50 , 113 -, 108
, 67 , 342 -
, 129 , 51 , 32 121 .
51 . Boiko A. et al. Early onset of multiple sclerosis. A longitudinal study. Neurology 2002;
59:1006-10, Ghezzi A. et. al. Multiple sclerosis in children: clinical features of 149 cases. Mul-
tiple sclerosis 1997; 3:43-6, Ruggieri M. et al. Multiple sclerosis under 6 years of age. Neurol-
ogy 1999(53):478-84, Hamard . et al. Infantile acute optic neuritis. Bulletin de VAcademie
National de Medecine 2000; 1984(7):1511-21.
52 Herndn M.A.et al. Recombinant hepatitis vaccine and the risk of multiple sclerosis. Neurol-
ogy 2004; 63:838-842.
, , , , . , , . 1992 . , , - . . , , , 1985-1988 . , . 70 , 47 , 107 , 42 , 22 , . , , . , , , - (, ), . 1994 . , , - ... !53 , , . , , , . , 1996 ., 2,5
|
|
53 Stratton . Adverse... p. 229.
, , , . 18 1999 ., , , , . , . - . , , ... ! .
, . , , , 12 ? ? ?
. , , , . , . 72 120 . , , , . , . , - . . . , , , 54. - , , . , , , ,
|
|
54 , 1 ; 2 . .
, , 55.
, , , , . , . , , , . ( ) , , , . , , , . , , ...
?
, , , . , ,
55 , , . , . (, 2001), - . : , 1- 610 . , , 21,6%. 73 (39,2%). 24 (12,9%) , . 23 (12,4%) , . 20 (10,8%). 18 (9,7%) . 15 (8,1%) , 12 (6,5%) . , : ... , ... 43% ( . . ... . 196). , , , .
56. . , . , , , , , , . , , . , , , , . , , ( ) , 57. , , , .
58.
1.
Bce | 14 | 14 | Bce | 14 | ||
61 997 | 2 651 | 51 305 | 2 302 | 28 471 | 1 477 | |
30 810 | 24 133 | |||||
14 | 14 | 14 | ||||
18 784 | 14 981 | 12 379 | ||||
7 502 | 6 890 | 6 455 |
1.
56 : , 140 000 320 000 (70 000 160 000 ), 10 000 ?. : , . . . 300% ( ) , - , . ? . , , , . 320 000 . . , , , , 900 . . , ( ) , . . PuliyelJ. M. Plea to restore public funding for vaccine development. Lancet 2004(363):659.
57 : . . ...
100 . ( ,
58 , , . -, ; -, - .
1990- 2000- . , 1 ).
2. ( 100 000 )
26,8 | 35,4 | 36,6 | 35,7 | 43,3 | 42,5 | 35,3 | 19,8 | 13,1 | 10,4 | 8,56 | |
3,2 | 6,8 | 9,1 | 11,6 | 20,9 | 21,1 | 16,7 | 7,1 | 5,2 | 4,8 | 4,47 |
2. ( 100 000 )
, 199759. 1997 ., 1998 . ( ) - . 1999 . 3% , 2000 . 10%; 90%, 95%, 2000 . ( 1999 .) . , , 2001 . , -